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https://doi.org/10.1016/j.stemcr.2019.04.012SUMMARYWe evaluate whether human induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) cells can be used to prioritize
and functionally characterize causal variants at age-related macular degeneration (AMD) risk loci. We generated iPSC-RPE from six
subjects and show that they have morphological and molecular characteristics similar to those of native RPE. We generated RNA-seq,
ATAC-seq, and H3K27ac ChIP-seq data and observed high similarity in gene expression and enriched transcription factor motif profiles
between iPSC-RPE and human fetal RPE. We performed fine mapping of AMD risk loci by integrating molecular data from the iPSC-RPE,
adult retina, and adult RPE, which identified rs943080 as the probable causal variant atVEGFA. We show that rs943080 is associated with
altered chromatin accessibility of a distal ATAC-seq peak, decreased overall gene expression of VEGFA, and allele-specific expression of a
non-coding transcript. Our study thus provides a potential mechanism underlying the association of the VEGFA locus with AMD.INTRODUCTION
Age-related macular degeneration (AMD) is a leading
cause of vision loss that affects 1.6 million people over
the age of 50 years in the United States (CDC, 2018)
and has limited therapeutic options (Al-Zamil and Yassin,
2017). Disease development manifests in progressive
degeneration in response to oxidative stress and inflam-
mation of the retinal pigment epithelium (RPE) (Kinnu-
nen et al., 2012), a monolayer consisting of a few million
cells most densely located in the macula of the eye
(Panda-Jonas et al., 1996). AMD has a strong genetic
component (Seddon et al., 2005), and through a large in-
ternational study of 16,144 AMD cases and 17,832 con-
trols, 52 independent AMD risk variants mapping to 34
AMD-associated loci have been identified (Fritsche et al.,
2016). As in many common diseases (Gallagher and
Chen-Plotkin, 2018; Gusev et al., 2014; Maurano et al.,
2012; Visscher et al., 2017), the majority of these loci
have strongly associated variants in non-coding regions
of the genome, suggesting that they may act through
gene regulation. Regulatory variants that affect human
disease, such as the variant that affects IRX3 expression
in obesity (Smemo et al., 2014), can have strong effects,
but it can be challenging to identify causal distal regulato-
ry variants and link them with their target genes. Indeed,St
This is an open access artifor AMD, while some candidate target genes have been
identified (Fritsche et al., 2016), the causal variants and
the downstream processes by which they mediate their
effects are generally unknown.
Regulatory genetic variation is often cell-type specific
and can be studied through genetic analysis of molecular
traits such as gene regulation and expression (Albert and
Kruglyak, 2015). However, characterizing genetic variation
in human RPE is challenging because the number of RPE
cells in the human eye is limited (Panda-Jonas et al.,
1996), can be affected by lifetime environmental expo-
sures, and requires invasive procedures to collect samples.
Induced pluripotent stem cell-derived RPE (iPSC-RPE) is a
promising alternative to human RPE for genetic studies as
a virtually unlimited number of cells can be obtained
with the same genetic background non-invasively.
iPSC-RPE has been shown to display characteristics of
mature human RPE including polygonal and pigmented
morphology, polarity of protein expression and secretion,
phagocytosis of photoreceptor outer segments, and main-
tenance of RPE phenotypes after transplantation into
mouse retina (Maruotti et al., 2015). Additionally, stem
cell-derived RPE have been effectively transplanted into
rodent and primate models, supporting their relevance
in vivo (Davis et al., 2017; Kamao et al., 2014; Stanzel
et al., 2014). Thus, iPSC-RPE could be an effective modelem Cell Reports j Vol. 12 j 1–12 j June 11, 2019 j ª 2019 The Author(s). 1
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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associated with AMD.
The identification and functional characterization of
causal genetic variants has been improved through fine-
mapping algorithms that can incorporate diverse epige-
netic annotations. For example, accessible chromatin and
active regulatory regions such as promoters and enhancers
marked by histone 3 lysine-27 acetylation (H3K27ac) have
been shown to be enriched for genetic variants associated
with human diseases in cell types relevant for disease and
can improve the prioritization of genome-wide association
study (GWAS) causal variants through fine-mapping strate-
gies (Pickrell, 2014). Additionally, while many GWAS loci
harbor genes that have been implicated in AMD, such as
VEGFA, which encodes the vascular endothelial growth
factor (VEGF) protein that is targeted by three current treat-
ments for AMD (Gragoudas et al., 2004; Heier et al., 2012;
Rosenfeld et al., 2006), the causal risk variant and the
mechanism of increased disease risk is not known. Thus,
the molecular characterization of gene expression and
regulatory regions in iPSC-RPE could improve fine map-
ping of AMD and lead to insights into mechanisms under-
lying genetic risk variants.
To investigate the utility of iPSC-RPE as a model system
to characterize AMD risk variants, we generated iPSC-RPE
from six human subjects and integrated gene expression,
chromatin accessibility, and H3K27ac chromatin immuno-
precipitation sequencing (ChIP-seq) data with comple-
mentary published data from human adult subjects to
identify potential causal variants at AMD risk loci. We
show that the iPSC-RPE shows morphological andmolecu-
lar characteristics that are similar to those of native
RPE including a characteristic polygonal shape, strong
melanin pigmentation and expression, and strong zonula
occludens 1 (ZO-1), bestrofin 1 (BEST1), and microphthal-
mia-associated transcription factor (MITF) immunostain-
ing. We show that iPSC-RPE gene expression profiles are
highly similar to that of human fetal RPE, and that their
ATAC-seq (assay for transposase-accessible chromatin us-
ing sequencing) peaks are enriched for relevant transcrip-
tion factor motifs. We performed fine mapping of AMD
risk loci integrating the molecular data from iPSC-RPE,
human fetal RPE, and published human retina and RPE
samples. At one locus, VEGFA, we show that the rs943080
risk allele is associated with regulatory protein binding in
iPSC-RPE in a potentially disease-dependent manner, and
that the risk allele results in decreased overall VEGFA
expression, potentially through regulation by a non-cod-
ing transcript. These results establish a molecular hypothe-
sis for the VEGFA genetic risk locus on AMD and illustrate
the potential of iPSC-RPE as a model system to study
the molecular function of genetic variation associated
with AMD.2 Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019RESULTS
Derivation of iPSC-RPE
To derive iPSC-RPE, we chose six induced pluripotent cell
(iPSC) lines fromunrelated individuals of African American
(1), European (3), and East Asian (2) ancestry in iPSCORE
that have been established as being pluripotent with low
levels of somatic variation (Panopoulos et al., 2017). We
then applied a slightly modified version of a protocol
validated by Maruotti et al. (2015) (Figure 1A) to differen-
tiate iPSC-RPE. The first pigmented foci of characteristic
polygonal cells appeared after 2–3 weeks, and virtually
all cells were strongly pigmented by day 84 (Figure 1B).
We assessed the purity of five out of six iPSC-RPE samples
at day 84 by flow cytometry and observed that a high frac-
tion of cells were ZO-1 and/orMITF positive (ZO-1+mean =
93.8% and range = 85.8%–99.4%;MITF+mean = 99.0% and
range = 98%–99.8%; ZO-1+MITF+ mean = 91.5% and
range = 87.2%–98.1%) (Figure 1C and Table S1). We also
examined two of the iPSC-RPE samples for characteristic
RPE marker proteins and observed membrane expression
of ZO-1 and BEST1 and nuclear expression of MITF (Fig-
ure 1D). Thus, the iPSC-RPE displayed many of the
morphological and molecular characteristics of RPE, con-
firming the robustness of the differentiation protocol.The Transcriptomes of Human iPSC-RPEAre Similar to
those of Fetal RPE
We first compared iPSC-RPE gene expression with fetal RPE
gene expression to examine their similarity overall and at
previously established RPE signature genes. We generated
RNA sequencing (RNA-seq) data for the six iPSC-RPE, as
well as one RPE obtained from a human fetal sample (Table
S1). Using principal component analysis (PCA) followed by
t-distributed stochastic neighbor embedding (t-SNE), we
examined global trends between the iPSC-RPE and the fetal
RPE RNA-seq in contrast to 222 iPSC lines (DeBoever et al.,
2017) and 144 iPSC-derived cardiomyocytes (iPSC-CMs)
(our unpublished data) for which we have previously
generated RNA-seq, as well as published RNA-seq data for
adult RPE (Wang et al., 2018), adult retina (Kim et al.,
2018; Wang et al., 2018), peripheral RPE-choroid-sclera
(Kim et al., 2018), fetal RPE (Melo et al., 2018), and the
ARPE-19 cell line (Oberstein and Shenk, 2017). When
analyzed jointly, we observed that iPSC-RPE grouped with
the fetal RPE samples, the adult RPE clustered with the pe-
ripheral RPE-choroid-sclera, and the adult retina clustered
with the peripheral retina (Figure 2A). These clustering
groups were similar when the iPSC and iPSC-CM samples
were excluded (Figure 2B). We additionally analyzed gene
ontology (GO) enrichments of genes with strong principal
component (PC) weights and observed enrichment for a
Figure 1. Differentiation of iPSC-RPE
(A) iPSC-RPE differentiation protocol.
(B) T150 flasks containing iPSC-RPE (iPSCORE 87_1) at day 84 (left). Bright-field image of iPSC-RPE sample (iPSCORE_42_1) at day 84
illustrating a highly organized monolayer with strong melanin pigmentation and characteristic polygonal shape (right).
(C) Flow-cytometry analysis of iPSC-RPE (iPSCORE_42_1) at day 84 showing high co-staining of zonula occludens 1 (ZO-1) and micro-
phthalmia-associated transcription factor (MITF).
(D) Immunofluorescence analysis of bestrofin 1 (BEST1) (iPSCORE_29_1), ZO-1 (iPSCORE_29_1), and MITF (iPSCORE_42_1).
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ment (GO:0007423, p = 5.2 3 1011, PC3) and sensory
perception of light stimulus (GO:0050953, p = 2.0 3
1019, PC4) (Figure S1 and Table S2). We also found that
genes associated with PC3 and PC4 were significantly
enriched for previously identified RPE signature genes
(Strunnikova et al., 2010) (p = 4.6 3 107 and 3.8 3
1020, respectively) and the expression patterns of these
signature genes in iPSC-RPE were similar to that of the fetal
RPE (Figure 2C). As a subset of these signature genes has
been previously reported to be different between fetal
RPE and stem cell-derived RPE (Liao et al., 2010), we exam-
ined their clustering pattern, but did not observe differen-
tial clustering (Figure 2C, ‘‘fetal, not stem-RPE’’). It is
possible that the high genomic integrity of the currently
studied iPSC lines or improvements to the differentiation
protocol (foci formation versus a continuous monolayer)
could have resulted in iPSC-RPE that were more similar to
fetal RPE. Furthermore, gene expression was highly corre-
lated between fetal RPE and iPSC-RPE across RPE signaturegenes (average r = 0.90, cor.test p < 1 3 106, example
shown in Figure 2D), suggesting that iPSC-RPE have tran-
scriptomes that are highly similar to those of fetal RPE.
Chromatin Accessibility of iPSC-RPE
We next examined whether the chromatin accessibility
profiles of the iPSC-RPE were similar to those of fetal or
adult RPE.We generated ATAC-seq data for the six iPSCORE
iPSC-RPEs, and for the fetal RPE (Table S1), and compared
them with published ATAC-seq data for RPE and whole
retina tissues from adults with and without AMD (Wang
et al., 2018). We compared the overlap of the accessible
chromatin regions in iPSC-RPE or fetal RPE with adult
RPE from both control and AMD subjects using the Jaccard
similarity metric and observed high similarity (Figure 2E).
We noted, however, that samples from the Wang et al.
(2018) study derived from subject ‘‘Donor 1’’ appeared to
be outliers with respect to the rest of the data. We therefore
labeled these six samples as ‘‘Late AMD Outlier.’’ We also
observed that one sample in our study (iPSCORE_71_1)Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019 3
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Figure 2. Gene Expression and Chromatin
Accessibility of iPSC-RPE and Other Eye
Samples
(A) tSNE plot based on the first 30 principal
components of RNA-seq using 10,000 of the
most variable genes. Samples include iPSCs,
iPSC-CMs, iPSC-RPE, and fetal RPE data
generated for this paper, and RPE and retina
samples from external public data sources
(see legend in B, inset).
(B) tSNE plot based on the first 30 principal
components of RNA-seq using 10,000 of the
most variable genes. In this case only sam-
ples related to RPE and retina are included.
(C) Heatmap showing expression levels of
RPE signature genes (Strunnikova et al.,
2010) in fetal RPE, iPSC-RPE, iPSC, and
iPSC-derived cardiomyocytes. Genes are
labeled by their gene group as annotated in
Liao et al. (2010).
(D) Scatterplot showing RNA-seq TPM for an
iPSC-RPE (iPSCORE_1_14) compared with
the fetal RPE sample for RPE signature
genes. Points are color coded according to
their classification in Liao et al. (2010) and
lines indicate linear regression best fits.
(E) Heatmap showing six iPSCORE iPSC-RPE
(iPSCORE_42_1, 17_1, 29_1, 1_14, and
87_1) and human fetal RPE ATAC-seq peaks
show stronger Jaccard similarity to native
RPE ATAC-seq peaks than retina ATAC-seq
peaks from adult eyes with and without AMD
(Wang et al., 2018). Columns are color
coded according to their AMD type and cell
type. Three RPE and three Retina samples
from the same subject with late AMD were
not similar with respect to the other RPE
and Retina samples and were labeled as
‘‘Late AMD Outlier.’’
(F) Heatmap showing similarity of tran-
scription factor (TF) binding site enrichment
in ATAC-seq peaks across samples. Color in-
dicates the TF’s rank of enrichment within
each sample with red indicating stronger
enrichment. Columns are color coded ac-
cording to their AMD type and cell type.
See also Figure S1.
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tionally Characterizing Causal Variants at AMD Risk Loci, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.04.012had a lower number of called peaks than the other
iPSC-RPE (Table S1) and showed lower similarity to the
data fromWang et al. (2018), indicating that it had overall
lower quality. However, as this sample was still more
similar to the RPE samples than the retina samples, we re-
tained it for downstream analyses. We then examined
whether the accessible regions displayed similar transcrip-4 Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019tion factor (TF) motif enrichments across all samples using
HOMER (Heinz et al., 2010).We observed high enrichment
for TF motifs important for RPE development and function
in all RPE samples including OTX2, CRX, and SOX9 (Table
S3). We compared the overall pattern of TF enrichment
of the fetal and iPSC-RPE with those from Wang et al.
(2018) by clustering the profiles by their enrichment rank
Please cite this article in press as: Smith et al., Human iPSC-Derived Retinal Pigment Epithelium: A Model System for Prioritizing and Func-
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across studies. We observed that the iPSC-RPE from this
study were most similar to the human fetal RPE and iPSC-
RPE samples in Wang et al. (2018) (Figure 2F). However,
we observed that the fetal and stem cell-derived RPE
showed a number of differences from both the adult
RPE and retina samples. These results suggest that iPSC-
RPE show a fetal-like regulatory program that is similar
to, but distinct from adult RPE and adult retina.
Enrichment of Regulatory Regions for AMD Genetic
Risk
To establish whether regulatory regions in iPSC-RPE could
be used to help identify potential causal variants for AMD,
we generated H3K27ac ChIP-seq data from the iPSC-RPE
and tested these and the chromatin accessibility regions
for enrichment of AMD genetic risk (Fritsche et al., 2016)
using fgwas (Pickrell, 2014), a statistical framework that in-
tegrates functional genomics annotations and GWAS sum-
mary statistics to identify putative causal variants at known
loci. We found that H3K27ac peak regions from fetal RPE,
as well as ATAC-seq peak regions from iPSC-RPE, fetal
RPE, adult AMD RPE, adult healthy RPE, and adult healthy
retina, were enriched for AMD genetic risk (Figure 3A). In
addition, exon regions and missense variants were also en-
riched. However, ATAC-seq regions from adult AMD (early
and late) retina samples, H3K27ac peak regions from iPSC-
RPE, and promoters showed positive associations, but were
not significantly enriched. We also observed that the re-
gions from the Late AMD Outlier samples showed deple-
tion for AMD risk and we therefore excluded these samples
from downstream analyses (Figure S2). Furthermore, iPSC-
RPE ATAC-seq and H3K27ac ChIP-seq regions from sub-
jects of different ethnicities showed overall similar levels
of enrichment and were therefore merged (Figure S2).
Using the annotations shown in Figure 3A, we created a
combined model that removes redundant annotations
and assesses the independent risk of each annotation (Fig-
ure 3B). We observed that while not all enrichments were
significant, fetal, iPSC, and adult RPE samples all provided
independent positive information for AMD risk. ATAC-seq
regions from retina samples, however, showed negative
enrichments, suggesting that the positive associations in
the single model were captured by the other annotations
and were RPE specific. These results indicate that chro-
matin accessibility regions in RPE from adults, fetal, and
iPSC-derived samples capture complementary risk regions
associated with AMD risk and could be used to improve
identification of potential causal variants.
Fine Mapping of AMD-Associated Loci with fgwas
To identify potentially causal variants associated with
AMD, we used fgwas to perform fine mapping of 32 ofthe 34 AMD risk loci for which we were able to obtain suf-
ficient data (see Experimental Procedures) based on the es-
timates from the combined model in Figure 3B. For each of
the 32 risk loci, we calculated 95% credible sets pre- and
post-prioritization (Table S4), and found that the prioritiza-
tion improved the number of variants in the credible set on
average from 28.9 to 23.5 (19% reduction). For 9 of the
32 risk loci, we identified a single variant with a posterior
probability of association (PPA) >0.8 (Table S4). Of these,
four showed strong shifts between their PPAs before and
after updating with the enrichments, including three loci
where the GWAS lead variant was not the prioritized
variant (COL8A1, CNN2, and C9), and one where the lead
variant was the prioritized variant (VEGFA) (Figure 3C).
To obtain insight into the types of regulation that could
be associated with each of the 32 GWAS loci, we examined
how the top variants prioritized by fgwas were associated
with each annotation and classified each into putative
functional classes according to their annotation patterns
(Figure 3D). Of the 32 fgwas lead variants, 21 were associ-
ated with an annotation. The majority of the variants
(16/21 [76%]) were located in regulatory regions, overlap-
ping both promoter (local regulatory, 6/21 [29%]) and
proximal regions (distal regulatory, 10/21 [48%]). An addi-
tional four were missense variants (coding, 4/21 [19%]).
One variant was located in an exon (in a 30 UTR), but was
not associated with other annotations, and was classified
as unknown (1/21 [5%]). We observed 13 regulatory vari-
ants with ATAC-seq annotations present in either iPSC-
RPE or adult AMD RPE (early- or late-stage AMD), of which
seven were present in both sample types. The remainder
were present only in iPSC-RPE (4/13) or only in adult
AMD RPE (2/13), suggesting that the majority of ATAC-
seq regions associated with AMD GWAS loci are present
in iPSC-RPE, but that in some cases they are only present
in adult RPE. Overall, these results establish a set of priori-
tized variants at AMD loci, identify four variants with high
PPA that were not previously distinguished from other var-
iants at their loci, and illustrate that iPSC-RPE and adult
RPE provide overlapping but complementary regulatory
annotations.
rs943080 Is Associated with Regulatory Effects on
VEGFA Expression
To examine the potential function of a SNP with a high
posterior probability of causality, we further examined
the molecular data associated with rs943080 at the VEGFA
locus. VEGFA is a strong candidate for the regulatory target
of this SNP as it is highly expressed in RPE and the SNP is
within a Hi-C chromatin loop identified in iPSCs (Green-
wald et al., 2019) associated with the VEFGA promoter
(Figure 4A). The rs943080 SNP is located 90 kb from the
start position of the VEGFA gene in a strong iPSC-RPEStem Cell Reports j Vol. 12 j 1–12 j June 11, 2019 5
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Figure 3. Fine Mapping of AMD GWAS Loci
(A) fgwas single enrichment of GWAS signal for multiple genome annotations. Black circles indicate ln(OR) and blue or gray lines show 95%
CIs. Blue indicates a significant positive enrichment.
(B) Final combined model used by fgwas to prioritize variants. Black circles indicate ln(OR) and blue, gray, or green lines show 95%
confidence intervals (colored to indicate significance different from 0; green negative, blue positive). Note that in this combined model,
associations reflect independent associations for each annotation and exclude annotations that did not significantly improve the model,
and so differ from single enrichments shown in (A).
(C) Scatterplot showing posterior probability of association (updated PPA) versus original posterior probability of association (original
PPA) for GWAS loci. GWAS lead SNPs are shown in gray. SNPs that were chosen as variant at the locus with the highest PPA by fgwas are
shown in blue. When the variant with the highest updated PPA is the GWAS lead variant, the points overlap. The four variants where the
fgwas prediction improved the PPA from <0.5 to >0.8 are labeled by their candidate gene and fgwas lead SNP.
(D) Heatmap indicating the presence (black) or absence (white) of each annotation for the 21 lead fgwas variants that were prioritized by
the model. The original and updated PPAs are shown in blue and are the same as in (C). Variants are grouped into variant functional classes
according to whether they were unknown, coding, local regulatory (located in promoters), or contained in distal regulatory (ATAC-seq or
H3K27ac without promoter) annotations.
See also Figure S2.
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rupt a TF motif or appear to create a new motif (data not
shown), the peak overlaps three motifs of TFs relevant for6 Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019the eye and/or RPE (SOX9 [Tang et al., 2015], COUP-TFI/II
[Tang et al., 2015], and ZIC3 [Zhang et al., 2004];
Figure 4C); additionally all three TFs were expressed in
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Figure 4. The rs943080 SNP Is Associated with Expression of VEGFA and Allele-Specific Expression of a Non-coding VEGFA Tran-
script
(A) Genomic region surrounding the genome-wide significant lead SNP near VEGFA showing AMD GWAS association (top), posterior
probability of causal association from fgwas for rs943080 (second from top), gene location and expression level in iPSC-RPE (third from
top), and Hi-C chromatin loops measured in iPSCs (bottom).
(B) Wig-coverage plots showing example ATAC-seq and RNA-seq data from iPSC-RPE. Two VEGFA transcripts are shown and the location of
rs943080 is indicated.
(C) rs943080 shows allele-specific expression of an ATAC-seq peak. TF motifs are shown at the top of example wig coverage plots from each
type of RPE samples (iPSC-RPE that is heterozygous for rs943080, iPSC-RPE that is homozygous risk for rs943080, RPE from normal adult
eyes, RPE from AMD eyes with early-stage disease, and RPE from AMD eyes with late-stage disease); the red line indicates the location of
rs943080 in the peaks (left). For each sample, the number of reads for the reference (non-risk) and alternative (risk) alleles are shown as a
bar plot; for heterozygous samples, the p value corresponds to a meta-analysis of tests of ASE using a binomial test (right). For data from
Wang et al., subjects are named Donors 1–5 within the Healthy group and Donors 1–5 within the AMD group. Samples from subjects with
AMD can fall into either Early or Late AMD, depending on pathology.
(D) Bar plot showing overall TPM gene expression for VEGFA in each of the iPSC-RPE samples. Bars are color coded by sample genotype, and
the edgeR p value for the difference between genotype groups is shown.
(legend continued on next page)
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been implicated in angiogenesis and regulation of VEGF re-
ceptor in the cardiovascular system (Pereira et al., 1999),
suggesting that it could also play a role in angiogenesis in
RPE. We first examined whether the ATAC-seq peak
showed allele-specific expression at the rs943080 SNP. For
the six subjects for which we obtained iPSC-RPE, we used
whole-genome sequence data to determine that five were
heterozygous for the rs943080 SNP (C/T) and one was
homozygous for the risk allele (T/T). Across the five hetero-
zygous subjects, we observed a significant allele-specific
effect (ASE) for the risk allele (p = 3 3 1012, Fig-
ure 4C), indicating that the risk allele was associated with
stronger chromatin accessibility. These results suggest
that rs943080 may act through allele-specific regulation
of the distal ATAC-seq peak.
To examine whether adult RPE samples also showed ASE,
we inspected allelic depth in the samples from Wang et al.
(2018). We observed reads for both alleles for two of the
three adult healthy RPE subjects, consistent with these in-
dividuals being heterozygous for the variant, but did not
observe significant ASE in these samples (p = 0.12), poten-
tially due to low comparative read depth. In the three adult
early-stage and two adult late-stage AMDRPE samples from
four subjects, we failed to observe any reads with the risk
allele, which could be explained because (1) they are all ho-
mozygous for the non-risk genotype or (2) in AMD samples
there is strong ASE for the non-risk allele. While we do not
have genotype data for these four subjects, given the risk
allele frequency (0.52 in European populations, higher in
other populations and in AMD subjects), it is unlikely
that they would all be non-risk homozygotes (probability =
0.003). Therefore, it is possible that the rs943080 variant
could show ASE of chromatin accessibility favoring the
non-risk allele in RPE from AMD subjects, in contrast to
the ASE of chromatin accessibility favoring the risk allele
in iPSC-RPE and adult healthy RPE. These results therefore
suggest that rs943080 is associated with differential chro-
matin accessibility in iPSC-RPE and healthy adult RPE,
but that it may act differently in an AMD context.
To examine whether the rs943080 SNP was also associ-
ated with VEGFA gene expression, we examined overall
expression levels and ASE in RNA from the iPSC-RPE sam-
ples. We observed that the five heterozygous samples
showed significantly higher overall gene expression than
the one homozygous risk sample (edgeR p = 0.04, Fig-
ure 4D), suggesting that the rs943080 risk allele may drive(E) ASE of VEGFA in the iPSC-RPE. Bar plots showing the allele frequenc
are heterozygous; ASE p values for overall gene expression from MBASE
of the SNPs relative to VEGFA transcripts and wig coverage plots of RNA
(iPSCORE_71_1) individual are shown (bottom); red dotted lines high
(ENST00000497139.1) and are driving the significant ASE association
8 Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019decreased VEGFA gene expression in RPE. Of note, rs94308
is not an expression quantitative trait locus for any GTEx
tissues (GTEx Consortium et al., 2017), but this could be
due to the fact that the interval around the SNP is only
annotated as an enhancer region in Roadmap (Roadmap
Epigenomics et al., 2015) in a small number of stem cell
or fetal tissues. Moreover, the five heterozygous samples
showed expression heterogeneity within them, suggesting
that additional factors also contribute to variation in
VEGFA expression.
We then further examined the transcriptome data and
identified two samples with significant ASE for VEGFA
RNA (iPSCORE_87_1 and iPSCORE_71_1, Figure 4E). To
determine whether the ASE was associated with a specific
region of theVEGFA transcripts, we examined the locations
and frequencies of the SNPs that were used to estimate ASE.
We found that the ASE for these two subjects was driven by
two SNPs that were located in an exon of a non-coding
transcript (ENST00000497139.1) and which did not over-
lap coding exons, suggesting that the ASE observation
could be restricted to the non-coding transcript. Consistent
with this model, we observed that a third SNP located in
the 30 UTR, which is shared across almost all VEGFA tran-
scripts, had high coverage in multiple samples and was
not associated with ASE. Thus, while rs943080 is associated
with an overall decrease in VEGFA expression, it may be
mediated not through ASE of all transcripts but rather
through a specific non-coding transcript.DISCUSSION
In this study, we have generated RNA-seq, ATAC-seq, and
H3K27ac ChIP-seq data from six human iPSC-RPE differen-
tiations as well as data from one human fetal RPE sample.
We integrated this data with published ATAC-seq data
from RPE and retina from adults with and without AMD
to prioritize specific variants at AMD risk loci. Themajority
of the variants whose prioritizations were altered by our
model were located in regulatory regions, although some
were also coding variants in genes. Overall, we observed
strong improvements in the prioritization of four variants,
including a potential regulatory SNP (rs943080) near
VEGFA and a coding SNP (rs34882957, pP167S) near the
C9 gene. While rs34882957 would not be expected to alter
gene expression or regulation, it has recently been shown
to be associated with increased serum concentrationies for six SNPs covering the VEGFA gene in each sample where they
D are listed for each sample on the right (top). The location of each
-seq data from a homozygote risk (iPSCORE_29_1) and heterozygote
light the two SNPs that overlap an exon of a non-coding transcript
in two individuals.
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merization (Kremlitzka et al., 2018), providing additional
support that the variant has functional effects on C9 that
could be involved in mediating AMD risk.
By examining RNA-seq and ATAC-seq data from individ-
uals with varying genotypes at the rs943080 SNP near
VEGFA, we suggest that the risk variant may result in
decreased gene expression of a non-coding transcript of
VEGFA in developing or normal RPE cells. While this tran-
script has not beenwell characterized, it is highly expressed
in many tissues (Gamazon et al., 2018) and could have a
regulatory role as it includes the 30 UTR, which has been
shown to have regulatory effects on translation (Ray
et al., 2009). Of note, there was one additional variant in
the VEGFA 95% credible set (rs7758685, PPA = 0.02) that
could also be considered a candidate for being causal, as
it shared the same genotypes as rs943080 in the six samples
and so was equivalently associated with VEGFA gene
expression. rs7758685 did not, however, occur in a regula-
tory region and we therefore could not perform an ATAC
ASE analysis to access its functionality. Given the strong
LD with rs7758685 and the fact that the strength of signif-
icance with altered gene expression was modest, future
experimental studies in appropriate model systems are
required to definitively show that the rs943080 SNP caus-
ally affects protein binding in RPE and gene expression of
VEGFA.
Our findings are relevant for the treatment of AMD, as
anti-VEGF is the only currently approved treatment for
‘‘wet’’ AMD that shows choroidal neovascularization.
While this treatment improves symptoms that are driven
by the growth of blood vessels, such as swelling and
bleeding, it is not clear that it stops progression of the
disease, and it may be associated with the further develop-
ment of geographic atrophy seen in ‘‘dry’’ AMD (Enslow
et al., 2016). Specific knockout of VEGFA in RPE in mice
has been shown to result in dysfunction and loss of the
choriocapillaris and cone photoreceptors, suggesting that
low levels of VEGFA gene expression could affect AMD pa-
thology (Kurihara et al., 2012). Our results are consistent
with this model and suggest that the rs943080 risk variant
could act through a reduction of VEGFA expression prior
to AMDonset.Wewere also able to examine the chromatin
accessibility of this region in previously published
ATAC-seq samples from adult RPE with and without
AMD. While we did not have access to genetic data for
these subjects, we observed biallelic accessibility in healthy
RPE samples and monoallelic accessibility in AMD RPE
samples with only the non-risk allele expressed. As
increased chromatin accessibility in healthy RPE was asso-
ciated with decreased VEGFA expression, it is plausible that
a lack of chromatin accessibility in AMDRPE samples could
be associated with increased VEGFA expression. Furtherstudy of the transcriptional effects of these variants in sub-
jects with genotype data is therefore needed.
We were able to gain insight into the VEGFA locus with
relatively few iPSC-RPE samples because we had a number
of heterozygous individuals as well as an individual who
was homozygous for the rs943080 risk allele. However,
for GWAS loci with many candidate target genes, larger
numbers of iPSC-RPEs will be required to characterize
ATAC ASE and changes in gene expression more generally.
Indeed, subsequent analyses of variants in the 95% credible
sets for the COL8A1 and CNN2GWAS loci showed that the
number of heterozygous sites in the iPSC-RPEs in our study
were too few to observe significant ATAC ASE effects. Thus,
to gain insight into functional genetic variation genome
wide, it will likely be necessary to obtain data for hundreds
of samples. As high-quality RPE samples are challenging to
obtain from human cadavers and because sample limita-
tions may restrict molecular characterization, iPSC-RPE
could potentially be generated from the hundreds of indi-
viduals needed. These data suggest that iPSC-RPE are well
suited for the genetic characterization of functional varia-
tion in RPE and that these large studies could aid in the
identification of causal variants at AMD risk loci.EXPERIMENTAL PROCEDURES
Please refer to Supplemental Experimental Procedures for detailed
methods.Sample Information
We obtained iPSC lines from iPSCORE (Panopoulos et al., 2017)
(Table S1) that were of diverse ancestries (3 European, 2 East Asian,
and 1 African American), age of donation, and were female. The
recruitment of these individuals was approved by the Institutional
Review Boards of the University of California, San Diego, and The
Salk Institute (project no. 110776ZF). Human fetal RPE cells were
purchased from Lonza.RPE Derivation and Characterization
To obtain iPSC-RPEs, we cultured iPSCs as amonolayer onMatrigel
in mTeSR1 medium. Once cells reached the desired confluence,
mTeSR1 medium was replaced with RPE differentiation medium
(RPE DM) and cells were cultured for 24 h. After 1 day, RPE DM
was supplemented with 10 mM nicotinamide (NIC) and 50 nM
chetomin. After 2 weeks, cells were cultured in RPE DM medium
supplemented with 10 mM NIC and then split at day 28 and day
56 with culturing in RPE medium until day 84.Cellular Data Generation
Flow-Cytometry Analysis
RPE were analyzed for ZO-1 and MITF co-expression using flow
cytometry. The fractions of ZO-1- and MITF-positive cells were
similar across all tested iPSC-RPE lines.Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019 9
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Fresh or cryopreserved iPSC-RPE cells from RPE001 and RPE005
at day 84 were characterized by immunofluorescence using anti-
ZO-1 antibody and a mouse monoclonal anti-MiTF antibody or
anti-ZO-1 and mouse monoclonal anti-BEST1 antibody.Molecular Data Generation and Processing
RNA-Seq
mRNA libraries were prepared and sequenced to 40million 150-bp
paired-end reads per sample. RNA-seq reads were aligned using
STAR with a splice junction database. Transcript and gene-based
expression values were quantified using the RSEM package and
normalized to transcript per million base pairs (TPM).
ATAC-Seq
We performed ATAC-seq, and libraries were sequenced to 80
million 150-bp paired-end reads. ATAC-seq reads were aligned us-
ing STAR to hg19, quality and insert size filtered, and peak calling
was performed using MACS2 on BAM files.
ChIP-Seq
For H3K27ac, formaldehyde crosslinked iPSC-RPE cells were
lysed and sonicated. For each sample, H3K27ac antibody was
used for overnight ChIP in IP buffer. Beads with immunoprecip-
itated chromatin were washed, eluted, and reverse crosslinked.
Reverse crosslinking samples were then purified, eluted, and
quantified. Libraries were generated, barcoded, and sequenced
to 40 million 150-bp paired-end reads. ChIP-seq reads were map-
ped to the hg19 reference using BWA. Reads were quality filtered
and peak calling was performed for each sample using MACS2
(Zhang et al., 2008) with reads derived from sonicated chro-
matin not subjected to IP used as a negative control.Data Analysis
RNA-Seq Analysis
PCA was performed on the 10,000 genes with the most variable
expression across all analyzed samples. Functional enrichment
of genes associated with each PC was performed using goseq.
Rtsne was used to perform t-SNE on the first 30 components
from the PCA. For each iPSC-RPE, we tested the correlation
between the expression of the log2(TPM) values for the
iPSC-RPE and the fetal RPE sample for each set of RPE signature
genes.
ATAC-Seq Analysis
ATAC-seq data were obtained from the Gene Expression Omnibus
(GEO: GSE99287). The five healthy donors were treated as unique
subjects. For the AMD samples, as samples from the same subject
could be annotated as early or late depending on the affected
status of the eye, the five AMD donors were treated as unique
subjects, whether or not the sample was annotated as early or
late AMD.
TF Enrichment
Enrichment for TF motifs was performed with HOMER using HO-
COMOCOv11 motifs. Sequences flanking the summits identified
by MACS2 were examined using findMotifsGenome. To cluster
TF motif profiles, we ranked the enrichment p values within
each sample across all TFs clustered and clustered them using hier-
archical clustering.10 Stem Cell Reports j Vol. 12 j 1–12 j June 11, 2019Measuring AMD GWAS Enrichment within Tissue ATAC-Seq
Peaks
Tomeasure the enrichment of AMDGWASwithin different tissues,
we applied fgwas on each set of ATAC-seq peaks independently.
Annotations for exonic, promoter, and UTR regions were obtained
from GENCODE. Annotations for missense and synonymous
variants were obtained from the 1,000 Genomes Project Phase 3.
Variants within each set of ATAC-seq peaks or other annotations
were input to fgwas, Z scores were calculated using the b and its
standard error, and fgwas was run using these Z scores and stan-
dard errors on consecutive 1-Mb intervals across the genome.
Fine Mapping of AMD GWAS Loci
To perform fine mapping of the AMD GWAS loci, we trained an
fgwas model containing annotations from ATAC-seq data,
H3K27ac data, and genome annotations. We applied fgwas on
these annotations, and used a cross-validation penalty of 0.30.
Finally, we removed annotations from the model until the likeli-
hood stopped increasing, resulting in 11 annotations from the
three types being retained. We used the model with fgwas to up-
date the Bayes factors for each variant using the cross-validation
estimated ridge parameter and calculated the posterior probability
of causality for each variant within 1-Mb windows flanking the
reported lead variant. The PPA is the proportion of the total
GWAS risk signal at a locus measured by Bayes factors that is
attributed to a particular variant, multiplied by the probability
that the genomic region contained a real signal.
VEGFA Locus Annotation
To visualize the VEGFA region, we plotted log10 p values along
with the PPA of all SNPs after prioritization with fgwas. TPM
normalized RNA-seq expression data from an iPSC-RPE was used
to identify expressed genes in the region.
ATAC-Seq Peak ASE of rs943080
To examine ASE at the ATAC-seq peak containing rs943080, we
measured allelic read depth. For each subject, an ASE p value was
calculated by testing the read depth counts to the expected fre-
quency (50%) using a binomial test. Across all heterozygotes, a
meta-analysis p was calculated. For the adult early- and late-stage
AMD samples, we calculated the probability of observing four sub-
jects with a homozygous reference genotype as the square of the
reference allele frequency in the 1,000 Genomes Project EUR pop-
ulation (0.48) to the fourth power.
RNA-Seq Analysis at VEGFA
Expression differences between the iPSC-RPE from the five subjects
heterozygous for rs943080 were compared with the one homozy-
gous subject. Reads counts were merged across all transcripts to
examine gene-level differences. ASE analysis of RNA-seq data was
performed, the number of read pairs supporting each allele was
counted, and heterozygous single-nucleotide variants (SNVs)
were retained if the reference or alternative allele had more than
eight supporting read pairs, the reference allele frequency was
between 2% and 98%, and the SNV was located in unique mapp-
ability regions.ACCESSION NUMBERS
ATAC-seq and RNA-seq data can be accessed through dbGaP:
phs000924, the Gene Expression Omnibus (GEO: GSE126847),
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Track Hub). The accession numbers for the additional ATAC-seq
and RNA-seq data reported in this paper are GEO: GSE99287,
GSE99248, GSE92346, and GSE99454.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.04.012.
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